C178H213ClF4N38O11S — CID 158281102
CID 158281102 (PubChem CID 158281102) has the molecular formula C178H213ClF4N38O11S and a molecular weight of 3204.00 g/mol. Its IUPAC name is (2-chlorophenyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;(2-cyclopentyloxyphenyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;(3,4-difluoro-2-methylphenyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;(5-ethylsulfonyl-2-fluorophenyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;(3-fluoro-2-pyridinyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;[6-(hydroxymethyl)-2-pyridinyl]-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]-quinolin-6-ylmethanone.
| Compound Name | CID 158281102 |
|---|---|
| PubChem CID | 158281102 |
| Molecular Formula | C178H213ClF4N38O11S |
| Molecular Weight | 3204.00 g/mol |
| Exact Mass | 3202.67 |
| IUPAC Name | (2-chlorophenyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;(2-cyclopentyloxyphenyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;(3,4-difluoro-2-methylphenyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;(5-ethylsulfonyl-2-fluorophenyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;(3-fluoro-2-pyridinyl)-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;[6-(hydroxymethyl)-2-pyridinyl]-[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]methanone;[(2S)-2-[6-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]-quinolin-6-ylmethanone |
| SMILES | CCS(=O)(=O)C1=CC(=C(C=C1)F)C(=O)N2CCCC[C@H]2C3=NN4C=C(C(=NC4=C3)N5CC[C@@H](C5)C)C.C[C@H]1CCN(C1)C2=NC3=CC(=NN3C=C2C)[C@@H]4CCCCN4C(=O)C5=CC6=C(C=C5)N=CC=C6.C[C@H]1CCN(C1)C2=NC3=CC(=NN3C=C2C)[C@@H]4CCCCN4C(=O)C5=C(C(=C(C=C5)F)F)C.C[C@H]1CCN(C1)C2=NC3=CC(=NN3C=C2C)[C@@H]4CCCCN4C(=O)C5=CC=CC=C5OC6CCCC6.C[C@H]1CCN(C1)C2=NC3=CC(=NN3C=C2C)[C@@H]4CCCCN4C(=O)C5=CC=CC=C5Cl.C[C@H]1CCN(C1)C2=NC3=CC(=NN3C=C2C)[C@@H]4CCCCN4C(=O)C5=CC=CC(=N5)CO.C[C@H]1CCN(C1)C2=NC3=CC(=NN3C=C2C)[C@@H]4CCCCN4C(=O)C5=C(C=CC=N5)F |
| InChI | InChI=1S/C29H37N5O2.C27H30N6O.C26H32FN5O3S.C25H29F2N5O.C24H28ClN5O.C24H30N6O2.C23H27FN6O/c1-20-14-16-32(18-20)28-21(2)19-34-27(30-28)17-24(31-34)25-12-7-8-15-33(25)29(35)23-11-5-6-13-26(23)36-22-9-3-4-10-22;1-18-10-13-31(16-18)26-19(2)17-33-25(29-26)15-23(30-33)24-7-3-4-12-32(24)27(34)21-8-9-22-20(14-21)6-5-11-28-22;1-4-36(34,35)19-8-9-21(27)20(13-19)26(33)31-11-6-5-7-23(31)22-14-24-28-25(18(3)16-32(24)29-22)30-12-10-17(2)15-30;1-15-9-11-30(13-15)24-16(2)14-32-22(28-24)12-20(29-32)21-6-4-5-10-31(21)25(33)18-7-8-19(26)23(27)17(18)3;1-16-10-12-28(14-16)23-17(2)15-30-22(26-23)13-20(27-30)21-9-5-6-11-29(21)24(31)18-7-3-4-8-19(18)25;1-16-9-11-28(13-16)23-17(2)14-30-22(26-23)12-20(27-30)21-8-3-4-10-29(21)24(32)19-7-5-6-18(15-31)25-19;1-15-8-11-28(13-15)22-16(2)14-30-20(26-22)12-18(27-30)19-7-3-4-10-29(19)23(31)21-17(24)6-5-9-25-21/h5-6,11,13,17,19-20,22,25H,3-4,7-10,12,14-16,18H2,1-2H3;5-6,8-9,11,14-15,17-18,24H,3-4,7,10,12-13,16H2,1-2H3;8-9,13-14,16-17,23H,4-7,10-12,15H2,1-3H3;7-8,12,14-15,21H,4-6,9-11,13H2,1-3H3;3-4,7-8,13,15-16,21H,5-6,9-12,14H2,1-2H3;5-7,12,14,16,21,31H,3-4,8-11,13,15H2,1-2H3;5-6,9,12,14-15,19H,3-4,7-8,10-11,13H2,1-2H3/t20-,25-;18-,24-;17-,23-;15-,21-;2*16-,21-;15-,19-/m0000000/s1 |
| InChIKey | GKFJIWLQUGMCPL-VOGUVOIHSA-N |
| XLogP | — |
| TPSA | 487.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 233 |
| Complexity | 5070 |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3204.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 39 |